Deciphera Pharmaceuticals Inc (DCPH)
25.45
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
25.46
+0.01
(+0.04%)
After-Hours: 20:00
Deciphera Pharmaceuticals Market Cap: 2.201B for May 16, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 2.201B |
| May 15, 2024 | 2.201B |
| May 14, 2024 | 2.200B |
| May 13, 2024 | 2.198B |
| May 10, 2024 | 2.193B |
| May 09, 2024 | 2.194B |
| May 08, 2024 | 2.194B |
| May 07, 2024 | 2.195B |
| May 06, 2024 | 2.194B |
| May 03, 2024 | 2.087B |
| May 02, 2024 | 2.087B |
| May 01, 2024 | 2.085B |
| April 30, 2024 | 2.078B |
| April 29, 2024 | 2.079B |
| April 26, 2024 | 1.205B |
| April 25, 2024 | 1.166B |
| April 24, 2024 | 1.202B |
| April 23, 2024 | 1.206B |
| April 22, 2024 | 1.198B |
| April 19, 2024 | 1.205B |
| April 18, 2024 | 1.169B |
| April 17, 2024 | 1.209B |
| April 16, 2024 | 1.219B |
| April 15, 2024 | 1.224B |
| April 12, 2024 | 1.236B |
| Date | Value |
|---|---|
| April 11, 2024 | 1.275B |
| April 10, 2024 | 1.282B |
| April 09, 2024 | 1.285B |
| April 08, 2024 | 1.233B |
| April 05, 2024 | 1.260B |
| April 04, 2024 | 1.244B |
| April 03, 2024 | 1.256B |
| April 02, 2024 | 1.248B |
| April 01, 2024 | 1.295B |
| March 28, 2024 | 1.271B |
| March 27, 2024 | 1.227B |
| March 26, 2024 | 1.197B |
| March 25, 2024 | 1.236B |
| March 22, 2024 | 1.231B |
| March 21, 2024 | 1.252B |
| March 20, 2024 | 1.273B |
| March 19, 2024 | 1.210B |
| March 18, 2024 | 1.200B |
| March 15, 2024 | 1.260B |
| March 14, 2024 | 1.286B |
| March 13, 2024 | 1.291B |
| March 12, 2024 | 1.300B |
| March 11, 2024 | 1.336B |
| March 08, 2024 | 1.369B |
| March 07, 2024 | 1.368B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
402.26M
Minimum
Mar 07 2022
3.768B
Maximum
Nov 16 2020
1.704B
Average
1.277B
Median
Oct 05 2022
Market Cap Benchmarks
| Bristol-Myers Squibb Co | 89.42B |
| Dynavax Technologies Corp | 1.476B |
| Gilead Sciences Inc | 84.54B |
| Esperion Therapeutics Inc | 490.70M |
| SINTX Technologies Inc | 17.18M |
Market Cap Related Metrics
| PS Ratio | 12.55 |
| Price to Book Value | 6.964 |
| Price | 25.45 |
| Earnings Yield | -8.68% |